<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04520776</url>
  </required_header>
  <id_info>
    <org_study_id>CT-20-001-001</org_study_id>
    <nct_id>NCT04520776</nct_id>
  </id_info>
  <brief_title>A Clinical Trial Comparing the BAGUERA C to the Marketed Mobi-C® for the Treatment of Single Level Cervical Disc Disease</brief_title>
  <official_title>A Multicenter, Prospective, Randomized, Clinical Trial Comparing the Safety and Effectiveness of the BAGUERA C Cervical Disc Prosthesis to the Mobi-C® Cervical Disc for the Treatment of Patients With Symptomatic Cervical Disc Disease at a Single Level</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Spineart USA</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Spineart USA</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The proposed investigation is a multi-center, prospective, randomized, controlled comparison&#xD;
      of the BAGUERA®C to the control, a similar, legally marketed total disc replacement device in&#xD;
      subjects with symptomatic cervical disc disease (SCDD). Subjects will be randomized in a 2:1&#xD;
      ratio to the one-level BAGUERA®C Cervical Disc Prosthesis (investigational group) or to the&#xD;
      one-level Mobi-C® Cervical Disc (control group). Subjects enrolled in the study will be&#xD;
      evaluated pre-operatively, at the time of surgery, discharge, and at 6 weeks, 3, 6, 12, and&#xD;
      24 months and then annually until 7 years post-surgery.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 2, 2021</start_date>
  <completion_date type="Anticipated">September 2024</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>participants will not be told their treatment group prior to surgery</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Neck Disability Index</measure>
    <time_frame>24 month follow-up visit</time_frame>
    <description>at least a 15 percentage point improvement (decrease) from baseline</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Maintenance or improvement in neurological status</measure>
    <time_frame>24 month follow-up visit</time_frame>
    <description>pre and post-op neurological examination to determine maintenance or improvement</description>
  </primary_outcome>
  <primary_outcome>
    <measure>No secondary surgical intervention per protocol definition</measure>
    <time_frame>24 month follow-up visit</time_frame>
    <description>any revision, removal, re-operation, or supplemental fixation at the index level</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Procedure or device related serious adverse events</measure>
    <time_frame>24 month follow-up visit</time_frame>
    <description>No serious adverse event(s) confirmed as device or procedure related as adjudicated by the Clinical Events Committee</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">270</enrollment>
  <condition>Cervical Disc Disease</condition>
  <arm_group>
    <arm_group_label>BAGUERA®C</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>surgical placement of the BAGUERA®C Cervical Disc Prosthesis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mobi-C®</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>surgical placement of the Mobi-C® Cervical Disc</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>BAGUERA®C Cervical Disc Prosthesis</intervention_name>
    <description>surgery</description>
    <arm_group_label>BAGUERA®C</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Mobi-C® Cervical Disc</intervention_name>
    <description>surgery</description>
    <arm_group_label>Mobi-C®</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        In order to be eligible to participate in this study, subjects must meet all of the&#xD;
        following criteria:&#xD;
&#xD;
          1. Male or female; skeletally mature; age 22-69 years, inclusive.&#xD;
&#xD;
          2. Diagnosis of radiculopathy or myeloradiculopathy of the cervical spine, with pain,&#xD;
             paresthesia or paralysis in a specific nerve root distribution C3 through C7,&#xD;
             including at least one of the following:&#xD;
&#xD;
               1. Neck and/or arm pain (at least 40 mm on the 100 mm visual analogue scale [VAS]&#xD;
                  scale).&#xD;
&#xD;
               2. Decreased muscle strength of at least one level on the clinical evaluation 0 to 5&#xD;
                  scale.&#xD;
&#xD;
               3. Abnormal sensation including hyperesthesia or hypoesthesia; and/or&#xD;
&#xD;
               4. Abnormal reflexes.&#xD;
&#xD;
          3. Symptomatic cervical disc disease (SCDD) at one level from C3 to C7.&#xD;
&#xD;
          4. Radiographically determined pathology at the level to be treated correlating to&#xD;
             primary symptoms including at least one of the following:&#xD;
&#xD;
               1. Decreased disc height on radiography, computed tomography (CT), or magnetic&#xD;
                  resonance imaging (MRI) in comparison to a normal adjacent disc.&#xD;
&#xD;
               2. Degenerative spondylosis on CT or MRI.&#xD;
&#xD;
               3. Disc herniation on CT or MRI.&#xD;
&#xD;
          5. NDI Score of ≥ 30% (raw score of ≥15/50).&#xD;
&#xD;
          6. Preoperative neck or arm pain ≥ 40 (out of 100) on Preoperative Neck and Arm Pain&#xD;
             Questionnaire.&#xD;
&#xD;
          7. Unresponsive to non-operative, conservative treatment (including but not necessarily&#xD;
             limited to: rest, heat, electrotherapy, physical therapy, chiropractic care and/or&#xD;
             analgesics) for:&#xD;
&#xD;
               1. Approximately six weeks from radiculopathy or myeloradiculopathy symptom onset;&#xD;
                  or&#xD;
&#xD;
               2. Have the presence of progressive symptoms or signs of nerve root/spinal cord&#xD;
                  compression despite continued non-operative conservative treatment.&#xD;
&#xD;
          8. Appropriate for treatment using an anterior surgical approach, including having no&#xD;
             prior surgery at the operative level and no prior cervical fusion or cervical&#xD;
             artificial disc procedure at any level.&#xD;
&#xD;
          9. Medically cleared for surgery.&#xD;
&#xD;
         10. Physically and mentally able and willing to comply with the Protocol, including the&#xD;
             ability to read and complete required forms and willing and able to adhere to the&#xD;
             scheduled follow-up visits and requirements of the Protocol.&#xD;
&#xD;
         11. Written informed consent provided by subject&#xD;
&#xD;
        Patients are not permitted to enroll in the one-level BAGUERA®C study if they meet any of&#xD;
        the following exclusion criteria:&#xD;
&#xD;
          1. Have an active systemic infection or infection at the operative site.&#xD;
&#xD;
          2. Have a history of or anticipated treatment for active systemic infection, including&#xD;
             HIV or Hepatitis C.&#xD;
&#xD;
          3. More than one immobile vertebral level between C1 to C7 from any cause including but&#xD;
             not limited to congenital abnormalities and osteoarthritic &quot;spontaneous&quot; fusions.&#xD;
&#xD;
          4. Previous trauma to the C3 to C7 levels resulting in significant bony or&#xD;
             disco-ligamentous cervical spine injury.&#xD;
&#xD;
          5. Had any prior spine surgery at the operative level.&#xD;
&#xD;
          6. Had a prior fusion or artificial disc procedure at any cervical level.&#xD;
&#xD;
          7. Axial neck pain alone in the absence of other symptoms of radiculopathy or&#xD;
             myeloradiculopathy.&#xD;
&#xD;
          8. Disc height less than 3 mm as measured from the center of the disc in a neutral&#xD;
             lateral position.&#xD;
&#xD;
          9. Radiographic confirmation of severe facet joint degeneration or confirmed clinical&#xD;
             evidence that facet joint degeneration is a major contributor to the subject's pain.&#xD;
&#xD;
         10. Have osteoporosis or osteopenia, defined as a DEXA bone density measured T-score of ≤&#xD;
             -1.5 (i.e. -1.6, -1.7, etc.). A DEXA performed within 24 months of the surgery date&#xD;
             may be used to determine eligibility. For subjects without a DEXA within 24 months of&#xD;
             the surgery date a score of ≥ 6 on either the SCORE or MORES requires a DEXA to&#xD;
             determine eligibility. Note: The SCORE (Simple Calculated Osteoporosis Risk&#xD;
             Estimation) form should be administered if the subject is female. The MORES (Male&#xD;
             Osteoporosis Risk Estimation Score) form should be administered if the subject is&#xD;
             male.&#xD;
&#xD;
         11. Have Paget's disease, osteomalacia or any other metabolic bone disease other than&#xD;
             osteoporosis, which is addressed above.&#xD;
&#xD;
         12. Have an active malignancy that includes a history of any invasive malignancy (except&#xD;
             non-melanoma skin cancer), unless the subject was treated with curative intent and&#xD;
             there had been no clinical signs or symptoms of the malignancy for at least five&#xD;
             years.&#xD;
&#xD;
         13. Symptomatic SCDD or significant cervical spondylosis at more than one level.&#xD;
&#xD;
         14. Spondylolysis.&#xD;
&#xD;
         15. Marked cervical instability on resting lateral or flexion-extension radiographs&#xD;
             demonstrated by:&#xD;
&#xD;
               1. Translation ≥ 3.5 mm, and/or&#xD;
&#xD;
               2. Greater than 11° angular difference to that of either adjacent level.&#xD;
&#xD;
         16. Known allergy to Titanium, Vanadium, Aluminum, cobalt, chromium, molybdenum or&#xD;
             polyethylene.&#xD;
&#xD;
         17. Segmental angulation of greater than 11° at treatment or adjacent levels.&#xD;
&#xD;
         18. Pregnant at time of enrollment, or with plans to become pregnant within the next three&#xD;
             years.&#xD;
&#xD;
         19. Have rheumatoid arthritis, lupus, or other autoimmune disease that affect the&#xD;
             musculoskeletal system.&#xD;
&#xD;
         20. Congenital bony and/or spinal cord abnormalities that affect spinal stability.&#xD;
&#xD;
         21. Have diseases or conditions that would preclude accurate clinical evaluation (e.g.&#xD;
             neuromuscular disorders, confirmed fibromyalgia, etc.).&#xD;
&#xD;
         22. Concomitant conditions requiring daily, high-dose oral and/or inhaled steroids. High&#xD;
             dose steroid use is defined as:&#xD;
&#xD;
               1. Daily, chronic use of oral steroids of 5 mg/day or greater.&#xD;
&#xD;
               2. Daily, chronic use of inhaled corticosteroids (at least twice per day).&#xD;
&#xD;
               3. Use of short-term (less than 10 days) oral steroids at a daily dose greater than&#xD;
                  40mg within one month of the study procedure.&#xD;
&#xD;
         23. Have current or recent history of substance abuse (alcoholism and/or narcotic&#xD;
             addiction) requiring intervention.&#xD;
&#xD;
         24. Severe Obesity, as defined by National Institutes of Health (NIH) Clinical Guidelines&#xD;
             Body Mass Index (BMI) &gt; 40).&#xD;
&#xD;
         25. Use of any investigational drug or other investigational medical device within the&#xD;
             last 30 days prior to surgery.&#xD;
&#xD;
         26. Taking medications known to interfere with bone/soft tissue healing (e.g., high-dose&#xD;
             oral and/or inhaled steroids, immunosuppressant medication, chemotherapeutic agents).&#xD;
             High dose steroid use is defined as part of Exclusion Criterion #22.&#xD;
&#xD;
         27. Have pending personal litigation relating to a spinal injury (does not include&#xD;
             worker's compensation).&#xD;
&#xD;
         28. Current history of heavy nicotine use (e.g. more than one pack of cigarettes per day).&#xD;
&#xD;
         29. Circumstances that may interfere with completion of follow-up examinations, including&#xD;
             location of residence.&#xD;
&#xD;
         30. Have mental illness or belong to a vulnerable population (e.g., prisoner or&#xD;
             developmentally disabled), that in the belief of the Investigator would compromise&#xD;
             ability to provide informed consent or compliance with other study requirements.&#xD;
&#xD;
         31. Have an uncontrolled seizure disorder.&#xD;
&#xD;
         32. Received cervical spine epidural steroids within 14 days prior to surgery.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>69 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Seth Kaufman</last_name>
    <phone>949-313-6400</phone>
    <phone_ext>1011</phone_ext>
    <email>skaufman@spineart.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Desert Institute for Spine Care</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85258</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Camoriano</last_name>
      <email>jennifer@jehnresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Huffman Clinic at Napa Valley Orthopaedic Group</name>
      <address>
        <city>Napa</city>
        <state>California</state>
        <zip>94558</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dawn Sousa</last_name>
      <email>dawn@napavalleyortho.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>HOAG Orthopedics</name>
      <address>
        <city>Orange</city>
        <state>California</state>
        <zip>92868</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edward Quilligan</last_name>
      <email>edward.quilligan@hoagorthopedics.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>UCSF Dept of Neurosurgery</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vivian Le</last_name>
      <email>Vivian.Le2@ucsf.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Spine Institute, Center for Spine Restoration</name>
      <address>
        <city>Santa Monica</city>
        <state>California</state>
        <zip>90403</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angel Chen</last_name>
      <email>angel@laspine.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Institute of Neuro Innovation</name>
      <address>
        <city>West Hills</city>
        <state>California</state>
        <zip>91307</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Seerat Jajj</last_name>
      <email>hjajj@inifoundation.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hartford Healthcare CT Orthopaedics</name>
      <address>
        <city>Hamden</city>
        <state>Connecticut</state>
        <zip>06518</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bethany Samperi</last_name>
      <email>Bethany.Samperi@hhchealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>NorthShore University</name>
      <address>
        <city>Evanston</city>
        <state>Illinois</state>
        <zip>60201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Boris Jancan</last_name>
      <email>bjancan@northshore.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Indiana Spine Group</name>
      <address>
        <city>Carmel</city>
        <state>Indiana</state>
        <zip>46032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sheetal Vinayek</last_name>
      <email>kelsey@oregonspinecare.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ortho NorthEast</name>
      <address>
        <city>Fort Wayne</city>
        <state>Indiana</state>
        <zip>46825</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tom Pawlik</last_name>
      <email>tpawlik@orthone.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Orthopaedic Institute of Western Kentucky</name>
      <address>
        <city>Paducah</city>
        <state>Kentucky</state>
        <zip>42001</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rebekah Vinson</last_name>
      <email>rvinson@oiwky.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Spine Institute of Louisiana</name>
      <address>
        <city>Shreveport</city>
        <state>Louisiana</state>
        <zip>71101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heather Bowman, RN</last_name>
      <email>heatherbowman@louisianaspine.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Southcoast Health</name>
      <address>
        <city>Fall River</city>
        <state>Massachusetts</state>
        <zip>02720</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ana Paz</last_name>
      <email>Paza@southcoast.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Carolina Neurosurgery and Spine Associates</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peggy Boltes, RN</last_name>
      <email>peggy.boltes@cnsa.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Ohio Sate University - Dept of Orthopedics</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hania Shahzad</last_name>
      <email>hania.shahzad@osumc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oregon Spine Care</name>
      <address>
        <city>Tualatin</city>
        <state>Oregon</state>
        <zip>97062</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelsey Gretzinger, PA-C</last_name>
      <email>kelsey@oregonspinecare.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Center for Sports Medicine &amp; Orthopedics</name>
      <address>
        <city>Chattanooga</city>
        <state>Tennessee</state>
        <zip>37404</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Danette Newton</last_name>
      <email>danettenewton@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. David's Healthcare</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78705</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Krishna Saini</last_name>
      <email>krishna.saini@stdavids.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Texas Back Institute</name>
      <address>
        <city>Plano</city>
        <state>Texas</state>
        <zip>75093</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shannon Rusch</last_name>
      <email>srusch@texasback.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Disc Replacement Center</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84088</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matt Allred</last_name>
      <email>mrallredrn@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>August 17, 2020</study_first_submitted>
  <study_first_submitted_qc>August 19, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 20, 2020</study_first_posted>
  <last_update_submitted>November 11, 2021</last_update_submitted>
  <last_update_submitted_qc>November 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>radiculopathy</keyword>
  <keyword>myeloradiculopathy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Diseases</mesh_term>
    <mesh_term>Intervertebral Disc Displacement</mesh_term>
    <mesh_term>Intervertebral Disc Degeneration</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Meloxicam</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

